Except for acute inflammatory-related pathway, mitogen-activated protein kinase (MAPK) signaling pathways and extracellular signal-regulated kinase (ERK) 1/2 signaling pathway were also changed in SLE patients (Figure 5E). This evidence concerns the gene WNK2 and systemic lupus erythematosus.